Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-057465

President and CEO sold 3,622 shares at $0.79 ($2,861)

From the SEC's structured data for this filing

Trades in this filing

Paulson Richard A. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-04 Sale : show line 1 in the form −3,622 $0.79 $2,861 787,579 D
Open-market sales · 3,622 sh · avg $0.79 · $2,861
Loading xslF345X05/doc4.xml…